Small Molecules

28 Aug 2019 Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein Degrader
28 Aug 2019 Ascletis Received IND Approval for its NASH Drug
28 Aug 2019 Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease
28 Aug 2019 Breztri Aerosphere Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease
27 Aug 2019 Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206
27 Aug 2019 Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy
27 Aug 2019 Basilea announces completion of patient enrolment in phase 1 study with oral BAL101553 in brain cancer
27 Aug 2019 Trovagene Presents Positive Clinical Data from Ongoing Phase 2 Study of Onvansertib in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
27 Aug 2019 InDex Pharmaceuticals Meets Primary Endpoint in the Phase IIb Study CONDUCT with Cobitolimod in Ulcerative Colitis
27 Aug 2019 LEO Pharma Files IND Application to FDA for a Clinical Study of JW1601/LP0190 in the US
24 Aug 2019 Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis
23 Aug 2019 Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
23 Aug 2019 Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN
22 Aug 2019 Snap Bio's Lead Candidate Overcomes Resistance of Approved Drugs for Liver Cancer
22 Aug 2019 Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer
22 Aug 2019 BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma
22 Aug 2019 U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
22 Aug 2019 ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every Two Months
22 Aug 2019 Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease
21 Aug 2019 Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
21 Aug 2019 Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis
21 Aug 2019 GSK submits first regulatory application for daprodustat in Japan for patients with renal anaemia due to chronic kidney disease
21 Aug 2019 Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years
20 Aug 2019 Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMD
20 Aug 2019 Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up